Form 4: Director Richard LaRoche Receives NHC Stock Option Grant
Statement of Changes in Beneficial Ownership
National HealthCare Corp director Richard F. LaRoche Jr. was granted 7,500 stock options as part of the 2020 Omnibus Equity Incentive Plan.
Summary
- Director Richard F. LaRoche Jr. received a grant of 7,500 stock options for National HealthCare Corp (NHC) common stock.
- The options were granted on May 7, 2026, with an exercise price of $171.42 per share.
- The options vest beginning May 7, 2027, and expire on May 6, 2031.
- The transaction was executed under the company's 2020 Omnibus Equity Incentive Plan.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation with no immediate impact on company operations or financial health.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
Negatives
- Potential future dilution of existing shareholders upon the exercise of these stock options.
Risks
- Market volatility affecting the value of the granted options.
- Regulatory risks associated with healthcare industry compliance.
Future Outlook
The filing does not provide forward-looking financial guidance, focusing solely on the disclosure of director equity compensation.
Management Comments
- The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
Industry Context
StockSavvy.ai notes that equity grants to directors are standard corporate governance practices in the healthcare services sector to ensure long-term alignment with shareholder interests.
Comparison to Industry Standards
- The use of an Omnibus Equity Incentive Plan is consistent with standard compensation practices for publicly traded healthcare companies.
- The grant size and vesting schedule are typical for non-executive director compensation packages in mid-cap healthcare firms.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation | Grant of 7,500 stock options to Director Richard F. LaRoche Jr. | 05/07/2026 | Neutral; standard incentive alignment. |
Stakeholder Impact
- Shareholders: Potential minor dilution upon future exercise of options.
Next Steps
- Vesting of the granted options on May 7, 2027.
Key Dates
| Date | Description |
|---|---|
| 05/05/2023 | Exercise date for 2022 option grant |
| 05/04/2025 | Exercise date for 2023 option grant |
| 05/07/2026 | Grant date of new options and filing date |
| 05/07/2027 | Vesting date for 2026 option grant |
Keywords
National HealthCare Corp, NHC, Form 4, Insider Trading, Stock Options, Equity Incentive Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.